Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy
Publication
, Conference
Denardo, JS; Davis, KE; Tcheng, JE
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 3, 2004
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 3, 2004
Volume
43
Issue
5
Start / End Page
31A / 31A
Location
New Orleans, LA
Publisher
ELSEVIER SCIENCE INC
Conference Name
54th Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Denardo, J. S., Davis, K. E., & Tcheng, J. E. (2004). Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 43, pp. 31A-31A). New Orleans, LA: ELSEVIER SCIENCE INC.
Denardo, J. S., K. E. Davis, and J. E. Tcheng. “Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43:31A-31A. ELSEVIER SCIENCE INC, 2004.
Denardo JS, Davis KE, Tcheng JE. Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2004. p. 31A-31A.
Denardo, J. S., et al. “Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 43, no. 5, ELSEVIER SCIENCE INC, 2004, pp. 31A-31A.
Denardo JS, Davis KE, Tcheng JE. Adjunctive pharmacotherapy during higher risk percutaneous coronary intervention: Eptifibatide-based antiplatelet therapy accompanied by only limited, specific antithrombin therapy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2004. p. 31A-31A.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
March 3, 2004
Volume
43
Issue
5
Start / End Page
31A / 31A
Location
New Orleans, LA
Publisher
ELSEVIER SCIENCE INC
Conference Name
54th Annual Scientific Session of the American-College-of-Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology